Oskare Capital
Investor profile
Venture capital
Oskare Capital has backed 3 European tech companies across 5 funding rounds between 2021 and 2026, joining rounds totalling €20M. Most active in Cleantech and Agritech. Data as of Nov 2026.
Deals
5
distinct rounds
Companies
3
backed
Active span
2021–2026
6 yrs
Total round €
€20M
sum of rounds joined
Deals by year
distinct rounds / yearOskare Capital — deals by year — interactive chart.
Data table
| Oskare Capital — deals by year | |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 1 |
Top sectors
by dealsOskare Capital — top sectors — interactive chart.
Data table
| Oskare Capital — top sectors | |
|---|---|
| Cleantech | 3 |
| Agritech | 1 |
| Healthtech | 1 |
Stages
by dealsOskare Capital — stages — interactive chart.
Data table
| Oskare Capital — stages | |
|---|---|
| Other | 3 |
| Seed | 1 |
| Series A | 1 |
Countries
by dealsOskare Capital — countries — interactive chart.
Data table
| Oskare Capital — countries | |
|---|---|
| Denmark | 3 |
| Italy | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Octarine Bio | Denmark | 3 | €11M |
| Herbolea Biotech | Italy | 1 | €5.0M |
| Leva Clinic | UK | 1 | €3.5M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Herbolea Biotech | Series A | €5.0M | 2021-11 |
| Octarine Bio | Other | €5.0M | 2026-01 |
| Octarine Bio | Other | €4.3M | 2023-11 |
| Leva Clinic | Other | €3.5M | 2022-11 |
| Octarine Bio | Seed | €2.0M | 2022-09 |